Suchergebnisse - "Taramasso, Lucia"

PubPharm (8)

1

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir

enthalten in: PloS one | 2023

von Squillace, N. | Ricci, E. | Maggi, P. | +20

2

Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens : Results from a Multicenter Prospective Cohort Study

enthalten in: Viruses | 2022

von Taramasso, L. | Falletta, A. | Ricci, E. | +14

3

Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV

enthalten in: AIDS research and human retroviruses | 2022

von Taramasso, L. | Lo Caputo, S. | Magnasco, L. | +12

4

The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen

enthalten in: AIDS (London, England) | 2020

von Taramasso, L. | Berruti, M. | Briano, F. | +1

5

Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine : Different effects in patients with or without baseline hypercholesterolemia

enthalten in: PloS one | 2019

von Taramasso, L. | Di Biagio, A. | Riccardi, N. | +7

6

Short Communication : Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?

enthalten in: AIDS research and human retroviruses | 2018

von Taramasso, L. | Riccardi, N. | Del Puente, F. | +5

7

Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?

enthalten in: Recent patents on anti-infective drug discovery | 2014

von Di Biagio, A. | Prinapori, R. | Taramasso, L. | +4

8

Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen

enthalten in: AIDS care | 2012

von Rosso, R. | Di Biagio, A. | Maggiolo, F. | +5

1
[1]